Skip to main content
. 2022 Jun 15;9:853582. doi: 10.3389/fcvm.2022.853582

TABLE 2.

Intraoperative results, early and long term outcomes.

All, n = 66 Septal thickness < 18 mm (n = 29) Septal thickness ≥ 18 mm (n = 37) P-value
Aortic cross-clamp (min) 41.4 ± 10.6 (20–80) 41.9 ± 10.9 (20–65) 41.1 ± 10.6 (24–80) 0.7
Cardiopulmonary bypass (min) 56.5 ± 12.7 (25–105) 56.8 ± 13.7 (25–88) 56.2 ± 12.1 (38–105) 0.8
Resected cords (n) 3.5 ± 1.6 (0–8) 3.5 ± 1.6 (0–8) 3.5 ± 1.6 (0–7) 0.9
Procedures on papillary muscles (n) 1.3 ± 0.8 (0–3) 1.4 ± 0.9 (0–3) 1.2 ± 0.8 (0–2) 0.4
Mitral valve replacement 2 (3) 0 2 (3) 0.4
Intraoperative mitral valve replacement for MR 1 (1) 0 1 (1) 0.4
Posterior mitral leaflet shortening 4 (6) 4 (6) 0 (0) 0.033
Other procedures 6 (9) 4 (6) 2 (3) 0.3
Blood transfusion 37 (56) 17 (25) 20 (30) 0.8
Re-exploration 1 (1) 1 (1) 0 (0) 0.4
Low cardiac output syndrome 2 (3) 1 (1) 1 (1) 1
Sepsis 3 (4) 1 (1) 2 (3) 1
Post-operative atrial fibrillation 33 (50) 11 (16) 22 (34) 0.1
Post-operative PM implantation 3 (4) 2 (3) 1 (1) 0.5
Post-operative Complete AV block 0
Iatrogenic ventricular septal defect 0
Length of stay (days) 10.6 ± 8.3 (5–62) 10.1 ± 6 (5–33) 10.9 ± 9.8 (5–62) 1
Pre-discharge SAM 2 (3) 1 (1) 1 (1) 1
Pre-discharge
LVOT gradient* (mmHg) 15.4 ± 8.5 (0–33) 14.7 ± 8 (0–30) 16 ± 8.8 (0–33) 0.5
Septal thickness (mm) 14 ± 2.6 (7–16) 12.7 ± 1.4 (10–16) 15 ± 2.9 (7–16) 0.0001
NYHA functional class 1.3 ± 0.5 (1–3) 0.7
I–II 63 (95) 27 (41) 36 (55) 0.7
III 3 (5) 2 (3) 1 (1)
MR grade 1.2 ± 0.6 (0–3) 0.2
≤ 1 + /4 + 50 (75) 25 (37.5) 25 (37.5)
2 + /4 + 15 (22) 4 (6) 11 (16)
3 + /4 + 1 (3) 0 1 (3)
Hospital mortality 0
Follow-up
SAM 7 (11) 2 (3) 5 (8) 0.5
LVOT gradient* (mmHg) 16.3 ± 8.8 (6–40) 18.2 ± 9.2 (6–40) 14.8 ± 8.2 (8–39) 0.1
Septal thickness (mm) 13.9 ± 2.7 (9–16) 12.9 ± 1.9 (10–18) 14.8 ± 3 (9–16) 0.0068
NYHA functional class 1.6 ± 0.6 (1–3) 0.9
I 27 (43) 11 (17) 16 (25)
II 35 (54) 16 (25) 19 (29)
III 2 (3) 1 (1) 1 (1)
MR grade 1.2 ± 0.5 (0–4) 0.6
≤ 2 + /4 + 62 (98) 28 (44) 34 (54)
4 + /4 + 1 (2) 0 1 (1)
Reoperation at follow-up for MR 0
Exitus at follow-up 2 (3) 1 (1.5) 1 (1.5) 1

MR, mitral regurgitation; PM, pacemaker; AV, atrio-ventricular; SAM, systolic anterior motion. LVOT, left ventricle outflow tract; NYHA, New York Heart Association.

*Peak gradient at rest.

Continuous variables were expressed as mean, standard deviation and range.

Categorical variables were expressed as absolute value and percentage.

Bold values are referred to the significative p value.